Complete Filing Data
MDxHealth SA reported Sales And Marketing Expense of $40.98 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean MDxHealth SA did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Sales And Marketing Expense | $41.0M | $36.9M | $25.7M | $17.5M | $16.8M | $17.8M |
| Research And Development Expense | $10.6M | $6.4M | $5.5M | $5.6M | $4.5M | $9.0M |
| Profit Loss From Operating Activities | -$24.7M | -$27.3M | -$37.9M | -$26.8M | -$27.1M | -$43.2M |
| Profit Loss Before Tax | -$37.7M | -$43.1M | -$44.0M | -$29.0M | -$28.7M | -$43.7M |
| Profit Loss | -$38.1M | -$43.1M | -$44.0M | -$29.0M | -$28.7M | -$43.1M |
| Gross Profit | $55.1M | $43.9M | $19.2M | $10.6M | $8.0M | $30.0K |
| General And Administrative Expense | $22.8M | $23.0M | $23.3M | $13.9M | $14.0M | $15.2M |
| Cost Of Sales | $34.9M | $26.3M | $17.8M | $11.7M | $10.4M | $11.8M |
| Comprehensive Income | -$38.1M | -$43.2M | -$43.5M | -$28.7M | -$29.0M | -$42.8M |
| Other Comprehensive Income | -$22.0K | -$149.0K | $593.0K | $264.0K | -$383.0K | |
| Income Tax Expense Continuing Operations | $382.0K | $1.0K | $0.00 | $0.00 | $0.00 | -$575.0K |
| Royalties And Other Revenues | $228.0K | $89.0K | $302.0K | $146.0K | $92.0K | |
| Total Other Comprehensive Incomeloss | $593.0K | $264.0K | -$383.0K | $253.0K | ||
| Impairment | $44.0K | $0.00 | $273.0K | $6.3M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $1.2M | $2.7M | $2.8M | $896.0K | $537.0K | $73.0K | |
| Cash Flows From Used In Operations Before Changes In Working Capital | -$14.7M | -$19.4M | -$32.6M | -$22.9M | -$22.2M | -$32.6M | |
| Cash Flows From Used In Operations | -$24.7M | -$27.3M | -$37.9M | -$26.8M | -$27.1M | -$43.2M | |
| Cash Flows From Used In Operating Activities | -$18.5M | -$21.5M | -$34.1M | -$22.5M | -$20.2M | -$22.3M | |
| Cash Flows From Used In Investing Activities | -$1.6M | -$3.9M | -$29.0M | -$885.0K | -$537.0K | -$73.0K | |
| Cash Flows From Used In Financing Activities | $44.6M | $32.3M | $20.7M | $66.5M | $14.3M | $18.0M | |
| Adjustments For Increase Decrease In Trade Account Payable | $458.0K | $20.0K | $4.0M | $1.3M | $234.0K | -$2.5M | |
| Adjustments For Decrease Increase In Trade Account Receivable | -$3.2M | -$1.7M | -$5.1M | -$1.4M | $2.9M | $12.2M | |
| Issue Of Equity | $40.7M | $39.6M | $5.0M | $68.6M | $14.2M | $10.0M | |
| Cash And Cash Equivalents | $46.8M | $22.4M | $15.5M | $58.5M | $16.0M | ||
| Netdecrease In Cash And Cash Equivalents | $6.9M | -$42.4M | $43.1M | -$6.5M | -$4.4M | ||
| Goodwill | $35.9M | $35.9M | $35.9M | $0.00 | |||
| Trade And Other Current Receivables | $14.4M | $11.1M | $9.4M | $4.6M | $3.8M | ||
| Trade And Other Current Payables To Trade Suppliers | $8.0M | $8.8M | $10.2M | $7.5M | $5.3M | ||
| Rightofuse Assets | $8.6M | $5.0M | $4.1M | $3.3M | $2.7M | ||
| Retained Earnings | -$369.5M | -$331.4M | -$288.3M | -$244.3M | -$215.3M | ||
| Purchase Of Intangible Assets Classified As Investing Activities | $971.0K | $2.3M | $1.4M | $0.00 | $0.00 | ||
| Property Plant And Equipment | $4.4M | $5.0M | $3.8M | $1.7M | $973.0K | ||
| Payment Of Longterm Debt | $1.7M | $10.8M | $0.00 | $0.00 | $589.0K | ||
| Other Noncurrent Financial Liabilities | $41.4M | $63.3M | $53.5M | $1.5M | $690.0K | ||
| Other Current Liabilities | $6.6M | $5.7M | $4.0M | $2.7M | $3.2M | ||
| Other Current Financial Liabilities | $26.4M | $2.9M | $2.3M | $961.0K | $909.0K | ||
| Noncurrent Liabilities | $99.8M | $102.4M | $91.5M | $11.7M | $13.0M | ||
| Noncurrent Lease Liabilities | $7.4M | $3.6M | $3.1M | $2.6M | $2.0M | ||
| Noncurrent Assets | $90.4M | $91.0M | $90.0M | $8.5M | $8.8M | ||
| Liabilities | $142.5M | $121.9M | $109.8M | $28.2M | $26.0M | ||
| Intangible Assets Other Than Goodwill | $40.6M | $44.3M | $46.2M | $3.4M | $5.1M | ||
| Equity And Liabilities | $157.3M | $129.1M | $119.1M | $75.1M | $31.9M | ||
| Current Liabilities | $42.7M | $19.5M | $18.3M | $16.4M | $13.0M | ||
| Current Lease Liabilities | $1.4M | $1.5M | $1.2M | $840.0K | $757.0K | ||
| Current Assets | $66.9M | $38.2M | $29.1M | $66.6M | $23.1M | ||
| Cash And Cash Equivalents Classified As Part Of Disposal Group Held For Sale | $15.5M | $58.5M | $16.0M | $22.1M | $26.2M | ||
| Assets | $157.3M | $129.1M | $119.1M | $75.1M | $31.9M | ||
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | $25.0M | $0.00 | $0.00 | ||||
| Prepaid Expenses And Other Current Assets | $2.0M | $1.6M | $1.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Payments Of Lease Liabilities Classified As Financing Activities | $1.9M | $1.6M | $1.4M | $1.1M | $831.0K | $815.0K |
| Proceeds From Issuing Shares | 40.7M | 39.6M | 0.00 | 68.6M | 13.9M | 9.6M |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | $25.0K | -$555.0K | -$520.0K | $394.0K | $244.0K | |
| Proceeds From Borrowings Classified As Financing Activities | $53.0M | $34.3M | $0.00 | $2.3M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Basic Earnings Loss Per Share | $-1.16 | $-1.66 | $-2.78 | $-2.38 | $-0.34 | $-0.69 |
| Diluted Earnings Loss Per Share | $-1.16 | $-1.66 | $-2.78 | $2.38 | $0.34 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Other Operating Income Expense | -$624.0K | -$461.0K | $559.0K | $1.2M | $118.0K | -$1.2M |
| Gains Losses On Exchange Differences On Translation Net Of Tax | -$22.0K | -$149.0K | $593.0K | $264.0K | -$383.0K | $253.0K |
| Finance Costs | $15.3M | $18.3M | $6.4M | $2.2M | $1.5M | $516.0K |
| Adjustments For Sharebased Payments | $1.7M | $665.0K | $867.0K | $1.2M | $1.3M | $872.0K |
| Adjustments For Decrease Increase In Inventories | -$1.1M | -$452.0K | -$416.0K | $413.0K | -$1.1M | $615.0K |
| Payment Of Interest | $3.6M | $1.4M | $1.0M | -$1.1M | -$324.0K | |
| Other Noncash Transactions | $421.0K | -$473.0K | -$325.0K | $26.0K | $1.0K | |
| Issued Capital | $214.7M | $173.9M | $133.5M | $128.5M | $76.7M | |
| Interest Received Classified As Investing Activities | $1.1M | $1.1M | $125.0K | $11.0K | $0.00 | $0.00 |
| Finance Income | $2.4M | $2.6M | $241.0K | $11.0K | $4.0K | $10.0K |
| Adjustments For Depreciation And Amortisation Expense | $2.4M | $1.7M | $1.4M | $3.3M | $3.4M | |
| Reserve Of Sharebased Payments | $17.1M | $12.1M | $11.5M | $10.6M | $9.4M | |
| Inventories | $3.9M | $2.8M | $2.3M | $1.9M | $2.3M | |
| Current Portion Of Longterm Borrowings | $324.0K | $643.0K | $616.0K | $4.4M | $2.8M | |
| Services | $37.0M | $21.9M | $18.1M | $11.4M | ||
| Licenses | $25.0K | $250.0K | $250.0K | $250.0K | ||
| Adjustments For Amortisation Expense | $4.9M | $4.5M | $3.2M | $1.6M | ||
| Share Premium | $153.2M | $153.2M | $153.2M | $153.2M | $136.3M | |
| Deduction Of Transaction Costs | -$6.8M | -$311.0K | -$458.0K | |||
| Translation Reserve | -$444.0K | -$1.0M | -$1.3M | |||
| Reserve Of Exchange Differences On Translation | -$615.0K | -$593.0K | -$444.0K | |||
| Repayments Of Borrowings Classified As Financing Activities | $39.5M | $1.7M | $10.8M | |||
| Loans And Borrowings | $34.9M | $7.7M | $10.3M |
Most recent annual filing with the SEC: March 31, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.